These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2316237)

  • 21. Impact of a community pharmacists' hypertension-care service on medication adherence. The AFenPA study.
    Fikri-Benbrahim N; Faus MJ; Martínez-Martínez F; Sabater-Hernández D
    Res Social Adm Pharm; 2013; 9(6):797-805. PubMed ID: 23391845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of a pharmacist-led clinic for hypertensive patients in primary care--a pilot study.
    Reid F; Murray P; Storrie M
    Pharm World Sci; 2005 Jun; 27(3):202-7. PubMed ID: 16096888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical pharmacy services in family practice: cost-benefit analysis. I. Physician time and quality of care.
    Chrischilles EA; Helling DK; Rowland CR
    Drug Intell Clin Pharm; 1984 Apr; 18(4):333-41. PubMed ID: 6425028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacist intervention program for control of hypertension.
    Chabot I; Moisan J; Grégoire JP; Milot A
    Ann Pharmacother; 2003 Sep; 37(9):1186-93. PubMed ID: 12921497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacist in the HMO environment.
    Middleton JK; Dee DA
    Contemp Pharm Pract; 1980; 3(4):268-70. PubMed ID: 10248869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of computerized treatment suggestions to improve health outcomes of outpatients with uncomplicated hypertension: results of a randomized controlled trial.
    Murray MD; Harris LE; Overhage JM; Zhou XH; Eckert GJ; Smith FE; Buchanan NN; Wolinsky FD; McDonald CJ; Tierney WM
    Pharmacotherapy; 2004 Mar; 24(3):324-37. PubMed ID: 15040645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct medical costs of Class IV HIV care.
    Shields AW; Anderson ES; Revis TR; Thompson RL; Mehring MA; Chi YP
    HMO Pract; 1990; 4(4):124-30. PubMed ID: 10105387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rational prescribing in primary care (RaPP): economic evaluation of an intervention to improve professional practice.
    Fretheim A; Aaserud M; Oxman AD
    PLoS Med; 2006 Jun; 3(6):e216. PubMed ID: 16737349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An off-site clinical pharmacy service in family medicine: development and 1-year outcomes.
    Vande Griend JP; Saseen JJ; Bislip D; Moore G; Conry C
    Fam Med; 2014 May; 46(5):348-53. PubMed ID: 24915477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice.
    Robinson JD; Segal R; Lopez LM; Doty RE
    Ann Pharmacother; 2010 Jan; 44(1):88-96. PubMed ID: 20040704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and implementation of a pharmacist-delivered Medicare annual wellness visit at a family practice office.
    Thomas MH; Goode JV
    J Am Pharm Assoc (2003); 2014; 54(4):427-34. PubMed ID: 25063263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of pharmacist intervention on control of resistant hypertension.
    Morse GD; Douglas JB; Upton JH; Rodgers S; Gal P
    Am J Hosp Pharm; 1986 Apr; 43(4):905-9. PubMed ID: 3706334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial.
    van der Laan DM; Elders PJ; Boons CC; Bosmans JE; Nijpels G; Hugtenburg JG
    Trials; 2017 Jan; 18(1):29. PubMed ID: 28103948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics service for ambulatory patients.
    Robinson JD
    Am J Hosp Pharm; 1981 Nov; 38(11):1713-6. PubMed ID: 7030071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacist involvement in primary care improves hypertensive patient clinical outcomes.
    Sookaneknun P; Richards RM; Sanguansermsri J; Teerasut C
    Ann Pharmacother; 2004 Dec; 38(12):2023-8. PubMed ID: 15522983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Having a practice pharmacist can reduce prescribing costs.
    Wells WD
    BMJ; 1998 Aug; 317(7156):473. PubMed ID: 9703540
    [No Abstract]   [Full Text] [Related]  

  • 37. [Place of clinical pharmacist in the management of drugs in patients with hypertension].
    Boyé F; Sallerin B; Ah Kang F; Arnaud A; Kantambadouno JB; Amar J; Chamontin B; Bouhanick B
    Ann Cardiol Angeiol (Paris); 2015 Jun; 64(3):216-21. PubMed ID: 26051854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes.
    Beney J; Bero LA; Bond C
    Cochrane Database Syst Rev; 2000; (3):CD000336. PubMed ID: 10908471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-care education: impact on HMO costs.
    Kemper DW
    Med Care; 1982 Jul; 20(7):710-8. PubMed ID: 7121090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of pharmacists and physicians on the quality of prescribing for ambulatory hypertensive patients.
    McGhan WF; Stimmel GL; Hall TG; Gilman TM
    Med Care; 1983 Apr; 21(4):435-44. PubMed ID: 6843196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.